PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth
2026-08-24T    Biotechnology   Health Care/Hospital   Medical Equipment 
ASTRI and Saint Francis University Sign MoU to Advance AI-Enabled Biomaterials and Digital Health Innovation
2026-08-24T    Biotechnology   Computer Networks   Computer Software   Computer/Electronics 
ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Pulnovo Medical Announces First Two U.S. Patients Enrolled in PULSE-LHD IDE Clinical Trial of Pulmonary Artery Denervation in Treating Pulmonary Hypertension Associated with Left Heart Disease
2026-08-24T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Henlius Reports 2026 Interim Results: Sustained Profitability Leap, Advancing Global Value Validation
2026-08-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved